An At-Home Option for Delmarva Patients
Getting consistent mental health care can be difficult when distance, work schedules, transportation, or cost make frequent clinic visits hard to manage.
Ketamine troches are dissolvable oral lozenges that may offer an at-home option under clinical guidance for appropriate patients. For some people on the Eastern Shore and across the Delmarva Peninsula, that flexibility can make ongoing care feel more manageable.
At KetaMed, the question is not simply whether an at-home option is convenient. It is whether troches fit your symptoms, history, treatment goals, and overall care plan.
How Ketamine Troches Work
A ketamine troche is a small lozenge placed under the tongue or against the cheek, where it dissolves and is absorbed through the oral mucosa.
Troches differ from IV and IM ketamine because they are not administered through an infusion or injection. That difference affects how the medication is absorbed and how the experience may feel.
For patients who are considering ketamine troches in Salisbury as a treatment for depression, anxiety, PTSD, or related mood concerns, troches may be one option to discuss during a consultation.
How KetaMed Evaluates Troche Treatment
At KetaMed, troches are part of a broader clinical relationship, not a product offered without evaluation.
Before a troche prescription is considered, our clinical team reviews your mood history, treatment background, current medications, symptoms, and overall clinical presentation.
Troches are not appropriate for every patient. In some situations, in-clinic IV ketamine therapy or IM ketamine may be a more appropriate place to begin. We talk through those differences directly so you understand why a particular option may or may not fit your situation.
How Troches Differ From IV Ketamine
Sublingual ketamine has lower bioavailability than IV ketamine. In one pharmacokinetic study, the median absolute bioavailability of a sublingual ketamine formulation was 29%, compared with direct systemic delivery through IV administration (Rolan et al., 2014).
This can mean that the timing and subjective experience differ from an IV infusion. Individual response varies, and there is no single format that is right for everyone.
Our role is to help you understand the differences without overselling any one option. The goal is to find an approach that fits your needs, not to place every patient into the same treatment plan.
Planning for At-Home Use
Patients and family members often have questions about what at-home troche use may involve. Those questions are important.
KetaMed provides individualized guidance about use, timing, and follow-up as part of the treatment plan. You should have a clear understanding of the instructions and what to do if questions or concerns arise.
A prospective, open-label study of telehealth-supported at-home sublingual ketamine reported improvements in depression and anxiety symptoms among participants. However, those findings do not mean every patient, clinical setting, or treatment plan will have the same outcome (Hull et al., 2022).
Where Troches Fit in a Treatment Plan
For some patients, troches may be considered as an initial option. For others, they may be part of a maintenance plan following IV or IM treatment. In other cases, an in-clinic option may be recommended instead.
The right format depends on the full clinical picture. Your symptoms, treatment history, medical considerations, and day-to-day circumstances all matter.
Patients considering any form of ketamine care may also find it helpful to review the conditions we treat before deciding whether to schedule a consultation.
Frequently Asked Questions
What conditions are ketamine troches used for at KetaMed?
KetaMed may evaluate troches for patients with treatment-resistant depression, anxiety, PTSD, and related mood concerns. Troches are not used by KetaMed as a primary treatment for chronic pain.
Do I take troches every day?
Troche schedules vary by patient and clinical indication. Your provider will develop an individualized dosing plan and explain how to use the medication safely.
Can ketamine troches be used after IV or IM treatment?
Yes. Troches may be considered as an initial option or as a maintenance phase following IV or IM treatment, depending on the patient’s clinical history and response.
How do I get ketamine troches?
After a clinical evaluation, your provider will explain whether troches may be appropriate and review the prescription process, instructions, and follow-up plan.
Are ketamine troches covered by insurance?
KetaMed does not currently accept insurance for ketamine treatment. Troches are listed at $100 per dose; pricing and payment information can be reviewed during consultation.
Key Takeaways
- Ketamine troches are dissolvable oral lozenges that may offer an at-home option for appropriate patients.
- KetaMed considers troches after reviewing mood history, medications, symptoms, and treatment background.
- Sublingual ketamine has lower bioavailability than IV ketamine, with one study reporting a median of 29% (Rolan et al., 2014).
- Troches may be considered as an initial option or as maintenance following IV or IM treatment.
- Ketamine treatment for mental health conditions is off-label, and results vary by individual (Sanacora et al., 2017).
Considering Ketamine Troches
When you are already managing depression, anxiety, PTSD, or another ongoing mental health concern, treatment should fit your life as well as your clinical needs.
At KetaMed Infusion Center in Salisbury, we take time to understand what you have been managing, what you have already tried, and whether ketamine troches, IM ketamine therapy, IV treatment, or another approach may be appropriate.
Contact our team to request a consultation and discuss your options.
References
Hull, T. D., Malgaroli, M., Gazzaley, A., Akiki, T. J., Madan, A., Vando, L., Arden, K., Swain, J., Klotz, M., & Paleos, C. (2022). At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. Journal of Affective Disorders, 314, 59–67. https://doi.org/10.1016/j.jad.2022.07.004
Rolan, P., Lim, S., Sunderland, V., Liu, Y., & Molnar, V. (2014). The absolute bioavailability of racemic ketamine from a novel sublingual formulation. British Journal of Clinical Pharmacology, 77(6), 1011–1016. https://doi.org/10.1111/bcp.12264
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., & Nemeroff, C. B. (2017). A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry, 74(4), 399–405. https://doi.org/10.1001/jamapsychiatry.2017.0080
About Our Team
At KetaMed Infusion Center in Salisbury, MD, our clinical team, including Michelle Ridgeway, a board-certified Psychiatric Mental Health Nurse Practitioner, and Dr. Mirza Umair Baig, a board-certified Emergency Medicine physician, approaches each evaluation as a complete clinical picture rather than a single presenting complaint.
We offer IV ketamine, IM ketamine, and ketamine troches for patients with depression, anxiety, PTSD, bipolar disorder, OCD, and other complex mood presentations across the Delmarva Peninsula. Our team takes time to understand each patient’s full mood and treatment history before making any recommendation.
Medical Disclaimer
The content in this blog post is intended for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Ketamine troches may be prescribed off-label for mental health conditions. Results vary by individual. Always discuss treatment options, risks, and benefits with a qualified healthcare provider before making medical decisions. KetaMed Infusion Center is located in Salisbury, MD, and serves patients across the Delmarva Peninsula and Maryland Eastern Shore.